Source: Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Jon Zugazagoitia, Mercedes Biosca, Julio Oliveira, María Eugenia Olmedo, Manuel Dómine, Ernest Nadal, José Carlos Ruffinelli, Nerea Muñoz, Ana María Luna, Berta Hernández, Maite Martínez, Iria Gallego, Eva Martínez de Castro, Carme Font, Virginia Calvo, Virginia Martínez-Marín, Jesús Corral, Esther Noguerón, Rebeca Mondéjar, Ignacio García Escobar, Carmen Salvador-Coloma, Óscar Juan, Manuel Sánchez Cánovas, Javier Valdivia, M. Pilar Ochoa, Rafael López Castro, Berta Obispo, Cristina Pangua, María Sereno, Lourdes Fernández Franco, Xabier Mielgo, Julia Calzas, Ana Blasco, Francisco Aparisi, Luis Chara, Juan Francisco Grau, Marta Soares, Ana Gómez, Victor Zenzola, Marcial García-Morillo, Diego Cacho, Asunción Díaz-Serrano, Carlos Aguado, Santiago Ponce-Aix, Jose Luis González-Larriba, Andrés J. Muñoz, David Lora, Luis Paz-Ares, Aránzazu Manzano. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer. Eur Respir J, 51 (5) 1702431; 10.1183/13993003.02431-2017

Member's Comments

No comment yet.

Related content which might interest you: Prognostic factors affecting survival in advanced non-small cell lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004 Effects of prognostic factors on survival of the patients of non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 326s Year: 2005 Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Study on coagulation abnormality and effect of anticoagulation on prognosis in advanced cases of non-small cell lung cancer Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy Source: Eur Respir Rev 2013; 22: 565-576 Year: 2013 Prognostic significance of tumour-related factors in resectable nonsmall-cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Prognostic value of comorbidity in operated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 763s Year: 2006 Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 431s Year: 2003 Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease. Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020 Characteristics, incidence, risk factors, and practical management of pneumonitis associated with anti-PD-1 immunotherapy in patients with non-small cell lung cancer Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Trail receptors as prognostic factors in non-small cell lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Prognostic factors in patients with resected pathologic stage I and II nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002